Dr. Reddy’s to Rename Semaglutide Drug Following Court Concerns
Brand Name Change Underway
New Delhi – Dr. Reddy’s Laboratories informed the Delhi High Court on Friday that it intends to change the brand name of its semaglutide drug from ‘Olymviq’ to ‘Olymra’. This decision follows a judge’s...
brand name change
diabetes
dr. reddy's laboratories
drug approval
generic drugs
glp-1 receptor agonist
india
legal dispute
novo nordisk
olymra
olymviq
ozempic
pharmaceuticals
semaglutide
type 2 diabetes
Novo Nordisk Drops Lawsuit Against Hims & Hers After Agreement to Sell Wegovy and Ozempic Through Platform
Novo Nordisk has dropped its lawsuit against telehealth company Hims & Hers after both firms reached an agreement that will allow the pharmaceutical company’s branded weight loss...
drug advertising
drug development
fda regulations
glp-1 drugs
hims & hers
injectable wegovy
legal dispute
novo nordisk
oral wegovy
ozempic
pharmaceutical companies
semaglutide
telehealth
wegovy
weight loss medication
